Hera

Male factor is involved in close to half of infertility cases, yet the man's test is the one that most often never happens: labs are hard to find, the paperwork is manual and results arrive without guidance. Hera runs the semen analysis order end to end, from booking a lab to an interpreted result and the next step.

Infertility is usually investigated as a woman's problem even though male factor contributes to a large share of cases. The man's workup is a chain of handoffs: find a lab that runs the test, get an order, book an appointment, wait, then receive a PDF that nobody explains. Many men drop out somewhere along that chain, and many abnormal results never lead to the follow-up that would find the cause.

Hera handles the whole order. It supplies the physician requisition, matches the patient to a certified lab nearby, and returns the result with an AI-derived fertility score and recommendations, while clinics can use the same rails for their own patients. Its place in Mayo Clinic Platform_Accelerate is about the part that matters most clinically: validating those models on real patient data. The founder previously co-founded Adracare, a telehealth platform acquired by WELL Health.